Yoga for Young Adults Affected by Cancer
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Yoga.
- Who it may be relevant to
- Registry conditions: Young Adult Cancer, Young Adult Oncology. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Canada
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Yoga for Young Adults Affected by Cancer: Exploring Implementation and Effectiveness of an Online Program
Overview
Yoga may enhance physical and psychological outcomes among young adults affected by cancer. Yet, yoga has rarely been studied in this population. We developed and piloted a yoga program, which is now ready for implementation and evaluation. This single-group, mixed-methods project will explore effectiveness and implementation of the yoga program.
Interventions
- Behavioral Yoga
Participants receive the yoga program, which is delivered by a trained yoga instructor (completed at least a 200-hour yoga teacher training, Yoga Thrive Teacher Training Certification (or similar), and/or practical experience working with individuals affected by cancer). The first class of the week is comprised of 45 minutes of gentle, progressive, hatha-based yoga sequencing and postures with the last 15 minutes focused on guided behaviour change and mindfulness techniques that varies week-to-w
Primary outcome measures
- Reach [Time frame: Through study completion, an average of 5 years]
Secondary outcome measures (12)
- Attendance [Time frame: Through study completion, an average of 5 years]
- Adherence [Time frame: Through study completion, an average of 5 years]
- Missing data [Time frame: Through study completion, an average of 5 years]
- Barriers and facilitators to exercise participation [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
- Physical activity levels [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
- Fatigue [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
- Cognition [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
- Cancer-related symptoms [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
- General health-related quality of life [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
- General well-being [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
- Mindfulness [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
- Self-compassion [Time frame: Baseline (week 0), post-program (week 12), 6-month follow-up (week 24), 1 year follow-up (week 52)]
Eligibility criteria
Inclusion criteria
- Adult aged 18 years or older;
- Diagnosed with cancer between the ages of 18-39 years;
- At any stage of their cancer experience (i.e., on- or off-treatment);
- Able to safely engage in yoga, as assessed by completing the Get Active Questionnaire and obtaining medical clearance (if indicated).
- Willing and able to complete informed consent, questionnaires, physical assessments, and an interview in English.
Exclusion criteria
1\. Previous enrolment in the study, to avoid contamination and/or ceiling effects.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Supportive care
Study locations
Canada · 1 center
- University of Calgary — Calgary
Publications
- Rogers LQ, Courneya KS, Verhulst S, Markwell S, Lanzotti V, Shah P. Exercise barrier and task self-efficacy in breast cancer patients during treatment. Support Care Cancer. 2006 Jan;14(1):84-90. doi: 10.1007/s00520-005-0851-2. Epub 2005 Jul 9. PMID 16007455
- Godin G, Shephard RJ. A simple method to assess exercise behavior in the community. Can J Appl Sport Sci. 1985 Sep;10(3):141-6. PMID 4053261
- Acaster S, Dickerhoof R, DeBusk K, Bernard K, Strauss W, Allen LF. Qualitative and quantitative validation of the FACIT-fatigue scale in iron deficiency anemia. Health Qual Life Outcomes. 2015 May 17;13:60. doi: 10.1186/s12955-015-0257-x. PMID 25980742
- Wagner L, Sweet J, Butt Z, Lai J-S, Cella D. Measuring patient self-reported cognitive function: development of the functional assessment of cancer therapy-cognitive function instrument. J Support Oncol, 2009. 7(6): W32-W39.
- Chang VT, Hwang SS, Feuerman M. Validation of the Edmonton Symptom Assessment Scale. Cancer. 2000 May 1;88(9):2164-71. doi: 10.1002/(sici)1097-0142(20000501)88:93.0.co;2-5. PMID 10813730
- Pickard AS, De Leon MC, Kohlmann T, Cella D, Rosenbloom S. Psychometric comparison of the standard EQ-5D to a 5 level version in cancer patients. Med Care. 2007 Mar;45(3):259-63. doi: 10.1097/01.mlr.0000254515.63841.81. PMID 17304084
- Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol. 1993 Mar;11(3):570-9. doi: 10.1200/JCO.1993.11.3.570. PMID 8445433
- Brown KW, Ryan RM. The benefits of being present: mindfulness and its role in psychological well-being. J Pers Soc Psychol. 2003 Apr;84(4):822-48. doi: 10.1037/0022-3514.84.4.822. PMID 12703651
Identifiers
NCT: NCT05314803 · HREBA.CC-20-0098 (sub-study)